LQDA - Liquidia Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$63.00
DETAILS
HIGH:
$67.00
LOW:
$60.00
MEDIAN:
$62.00
CONSENSUS:
$63.00
UPSIDE:
3.31%
About Liquidia Corporation (https://www.liquidia.com)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Roger A. Jeffs | Chief Executive Officer & Director | 1962 | $2,121,744 USD |
| Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 1976 | $1,406,072 USD |
| Russell Schundler | General Counsel & Corporate Secretary | 1976 | $1,171,097 USD |
| Rajeev Saggar | Chief Medical Officer | 1975 | $1,166,848 USD |
| Scott Moomaw | Chief Commercial Officer | 1971 | $980,961 USD |
| Beth-Anne Lang | Senior Vice President of Global Regulatory Affairs | – | – |
| Christian Perez Font | Senior Vice President, Chief Compliance Officer & Associate General Counsel | – | – |
| Dana Boyle | Chief Accounting Officer | 1985 | – |
| Frank Bartolini | Senior Vice President of Market Access | – | – |
| Gareth Gwyn | Senior Vice President of Medical Affairs | – | – |
| Harold Alterson | Senior Vice President of Quality | – | – |
| Jason Adair | Chief Business Officer | 1972 | – |
| Matt Snow | Senior Vice President of Sales | – | – |
| Michael Hunter | Senior Vice President of Manufacturing Operations | – | – |
| Michael Post | Senior Vice President of Marketing | – | – |
| Sarah Krepp SPHR | Chief Human Resources Officer | 1982 | – |